特宝生物
(688278)
| 流通市值：239.69亿 | | | 总市值：239.69亿 |
| 流通股本：4.08亿 | | | 总股本：4.08亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 797,791,349.65 | 3,695,567,867.63 | 2,479,547,947.46 | 1,510,615,117.77 |
| 营业收入 | 797,791,349.65 | 3,695,567,867.63 | 2,479,547,947.46 | 1,510,615,117.77 |
| 二、营业总成本 | 608,608,067.39 | 2,481,201,979.55 | 1,721,216,914.12 | 1,025,083,005.41 |
| 营业成本 | 84,135,622.69 | 259,990,596.78 | 184,529,708.94 | 106,031,437.95 |
| 税金及附加 | 10,147,658.67 | 19,964,915.13 | 12,713,333.14 | 7,638,447.31 |
| 销售费用 | 328,374,104.33 | 1,451,400,170.59 | 1,009,177,664.4 | 598,906,025.59 |
| 管理费用 | 92,126,614 | 363,909,982.98 | 237,841,939.56 | 140,327,604.73 |
| 研发费用 | 93,643,656.62 | 388,025,752.66 | 279,335,347.75 | 174,802,367.14 |
| 财务费用 | 180,411.08 | -2,089,438.59 | -2,381,079.67 | -2,622,877.31 |
| 其中:利息费用 | 686,786.07 | 1,424,517.72 | 764,381.47 | 379,937.93 |
| 其中:利息收入 | 904,206.22 | 4,042,479.94 | 3,388,066.3 | 2,896,353.29 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 3,890.42 | 3,448,015.83 | 1,069,749.2 | 590,535.23 |
| 加:投资收益 | 1,658,683.69 | 6,599,263.41 | 2,619,663.12 | 1,873,297.19 |
| 资产处置收益 | 626,708.78 | -718,026.13 | 14,474.43 | 14,090.2 |
| 信用减值损失(新) | 581,909 | -60,363.66 | 95,990.26 | 986,036.52 |
| 其他收益 | 6,579,864 | 27,008,206.26 | 19,255,943.07 | 8,153,402.56 |
| 四、营业利润 | 198,634,338.15 | 1,250,642,983.79 | 781,386,853.42 | 497,149,474.06 |
| 加:营业外收入 | 142,855.12 | 1,157,219.52 | 744,457.94 | 598,955.94 |
| 减:营业外支出 | 19,737,063.74 | 76,425,422.26 | 51,133,598.75 | 21,476,326.28 |
| 五、利润总额 | 179,040,129.53 | 1,175,374,781.05 | 730,997,712.61 | 476,272,103.72 |
| 减:所得税费用 | 14,545,654.32 | 144,138,528.47 | 64,873,930.74 | 48,377,992.51 |
| 六、净利润 | 164,494,475.21 | 1,031,236,252.58 | 666,123,781.87 | 427,894,111.21 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 164,494,475.21 | 1,031,236,252.58 | 666,123,781.87 | 427,894,111.21 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 164,494,475.21 | 1,031,236,252.58 | 666,123,781.87 | 427,894,111.21 |
| 扣除非经常损益后的净利润 | 165,332,467.09 | 1,062,128,487.04 | 673,034,942.06 | 431,339,041.81 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.4 | 2.53 | 1.64 | 1.05 |
| (二)稀释每股收益 | 0.4 | 2.52 | 1.64 | 1.05 |
| 八、其他综合收益 | - | - | -81,743.32 | - |
| 归属于母公司股东的其他综合收益 | - | - | -81,743.32 | - |
| 九、综合收益总额 | 164,494,475.21 | 1,031,236,252.58 | 666,042,038.55 | 427,894,111.21 |
| 归属于母公司股东的综合收益总额 | 164,494,475.21 | 1,031,236,252.58 | 666,042,038.55 | 427,894,111.21 |
| 公告日期 | 2026-04-29 | 2026-03-27 | 2025-10-23 | 2025-08-21 |
| 审计意见(境内) | | 标准无保留意见 | | |